Donald Kohn

Institution Name: 
University of California, Los Angeles
Total Awards: 
9
Award Value: 
$42,719,481

Awards as PI

Program Type Institution Grant Title Award Value
Disease Team Research I University of California, Los Angeles Stem Cell Gene Therapy for Sickle Cell Disease $8,833,695
Early Translational IV University of California, Los Angeles Beta-Globin Gene Correction of Sickle Cell Disease in Hematopoietic Stem Cells $1,651,884
Disease Team Therapy Development III University of California, Los Angeles Clinical Trial of Stem Cell Gene Therapy for Sickle Cell Disease $13,145,465
Clinical Trial Stage Projects University of California, Los Angeles A Phase I/II, Non Randomized, Multicenter, Open-Label Study of G1XCGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease $7,083,364
Conference II University of California, Los Angeles Primary Immune Deficiency Treatment Consortium (PIDTC) Annual Scientific Workshop $29,807
Quest - Discovery Stage Research Projects University of California, Los Angeles Hematopoietic Stem Cell Gene Therapy for X-linked Agammaglobulinemia $219,230
Clinical Trial Stage Projects University of California, Los Angeles Efficacy and safety of cryopreserved autologous CD34+ HSC transduced with EFS lentiviral vector encoding for human ADA gene in ADA-SCID subjects $5,827,000
Therapeutic Translational Research Projects University of California, Los Angeles Autologous MPO Knock-Out Hematopoietic Stem and Progenitor Cells for Pulmonary Arterial Hypertension $4,751,297
Quest - Discovery Stage Research Projects University of California, Los Angeles Hematopoietic Stem Cell Gene Therapy for Alpha Thalassemia $1,177,739
Total:
$42,719,481.00

Videos